Citation:Klingbiel D, Saridaki Z, Roth AD, Bosman FT, Delorenzi M, Tejpar S 2015

From Cancer Guidelines Wiki

Citation


Klingbiel D, Saridaki Z, Roth AD, Bosman FT, Delorenzi M, Tejpar S. Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial. Ann Oncol 2015 Jan;26(1):126-32 Available from: http://www.ncbi.nlm.nih.gov/pubmed/25361982.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Klingbiel D, Saridaki Z, Roth AD, Bosman FT, Delorenzi M, Tejpar S 2015Optimal molecular profilingBen Lee-Batescompleted
Klingbiel D, Saridaki Z, Roth AD, Bosman FT, Delorenzi M, Tejpar S 2015 2Optimal molecular profilingVictoria Freemancompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:Molecular profiling of CRC|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Molecular profiling of CRC</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:Molecular profiling of CRC|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Molecular profiling of CRC</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Optimal molecular profiling
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Klingbiel_D,_Saridaki_Z,_Roth_AD,_Bosman_FT,_Delorenzi_M,_Tejpar_S_2015&oldid=149723"